Partner Investment Management L.P. Takes Position in Elanco Animal Health (ELAN)

Partner Investment Management L.P. bought a new position in shares of Elanco Animal Health (NASDAQ:ELAN) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 9,518 shares of the company’s stock, valued at approximately $332,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ELAN. Primecap Management Co. CA acquired a new stake in Elanco Animal Health during the 3rd quarter worth $130,837,000. FMR LLC acquired a new stake in Elanco Animal Health during the 3rd quarter worth $114,567,000. Wells Fargo & Company MN acquired a new stake in Elanco Animal Health during the 3rd quarter worth $79,056,000. Janus Henderson Group PLC acquired a new stake in Elanco Animal Health during the 3rd quarter worth $68,975,000. Finally, Franklin Resources Inc. acquired a new stake in Elanco Animal Health during the 3rd quarter worth $60,016,000.

A number of analysts have commented on the stock. JPMorgan Chase & Co. began coverage on shares of Elanco Animal Health in a report on Monday, October 15th. They set an “overweight” rating and a $38.00 target price for the company. Morgan Stanley began coverage on shares of Elanco Animal Health in a research report on Monday, October 15th. They set an “equal weight” rating and a $35.00 price target on the stock. Bank of America began coverage on shares of Elanco Animal Health in a research report on Monday, October 15th. They set a “neutral” rating and a $34.00 price target on the stock. BMO Capital Markets lifted their price target on shares of Elanco Animal Health from $33.00 to $37.00 and gave the stock a “market perform” rating in a research report on Tuesday, November 13th. Finally, Cowen began coverage on shares of Elanco Animal Health in a research report on Monday, October 15th. They set an “outperform” rating on the stock. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $34.88.

In related news, CEO Jeffrey N. Simmons acquired 22,000 shares of the business’s stock in a transaction that occurred on Monday, September 24th. The shares were acquired at an average cost of $24.00 per share, with a total value of $528,000.00. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Lawrence Erik Kurzius acquired 10,000 shares of the business’s stock in a transaction that occurred on Monday, September 24th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $240,000.00. The disclosure for this purchase can be found here. Insiders purchased a total of 33,000 shares of company stock worth $792,000 over the last ninety days.

Shares of NASDAQ ELAN opened at $32.40 on Thursday. Elanco Animal Health has a twelve month low of $30.10 and a twelve month high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last posted its quarterly earnings data on Tuesday, November 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.25 by $0.04. The company had revenue of $761.10 million during the quarter, compared to the consensus estimate of $766.26 million. The company’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.14 earnings per share.

COPYRIGHT VIOLATION WARNING: “Partner Investment Management L.P. Takes Position in Elanco Animal Health (ELAN)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/12/06/partner-investment-management-l-p-takes-position-in-elanco-animal-health-elan.html.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

See Also: Compound Interest

Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply